跳至主要内容
临床试验/EUCTR2009-015914-23-GB
EUCTR2009-015914-23-GB进行中(未招募)不适用

Clinical efficacy of an experimental toothpaste

GlaxoSmithKline Consumer Healthcare (GSKCH)0 个研究点开始时间: 2009年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
  • Aged at least 18 years.
  • 3.Compliance
  • Understands and is willing, able and likely to comply with all study procedures and restrictions.
  • 4.General Health
  • Good general health in the opinion of the investigator, with no clinically significant and relevant abnormalities of medical history or physical examination.
  • 5.Dental Health
  • a)A minimum of 20 permanent gradable teeth. A scorable surface is defined as a surface that has 50% of the surface gradable. Third molars, orthodontically banded/ bonded, fully crowned or extensively restored, grossly carious or abutment teeth are not included in the tooth count.
  • b)Mild to moderate gingivitis present at the screening visit in the opinion of the investigator.
  • c)MGI between 1.50 and 2.30 at Pre-Prophy Baseline and Randomisation visit.
  • d)Reduction in MGI between Pre-Prophy Baseline and Randomisation visit.
  • e)All teeth required for plaque sampling are present (for sub-set of subjects undergoing plaque sampling only).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Pregnancy
  • Women who are known to be pregnant or who are intending to become pregnant over the duration of the study.
  • 2.Breast-feeding
  • Women who are breast–feeding.
  • 3.Allergy/Intolerance
  • Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
  • 4.Dental Health
  • a)Have current active caries or periodontitis that may compromise the study or the health of the subjects in the opinion of the investigator or MGI examiner.
  • b)Restorations in a poor state of repair.
  • c)Partial dentures or orthodontic appliances.
  • Current smokers or smokers who have quit within the past 6 months prior to screening.
  • 6.Medication
  • a)Currently taking antibiotics or have taken antibiotics in the 2 weeks prior to gingival health examinations.
  • b)Use of any systemic medication which would have an effect on gingival conditions within 14 days of gingival health examinations (e.g. calcium channel blockers, ibuprofen or aspirin therapy).
  • 7.Clinical Study/Experimental Medication
  • a)Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.
  • b)Previous participation in this study.
  • 8.Substance abuse
  • Recent history (within the last year) of alcohol or other substance abuse.
  • 9.Personnel
  • a)An employee of the sponsor or the study site or members or their immediate family.
  • b)An employee of any toothpaste manufacturer or their immediate family.

研究者

发起方
GlaxoSmithKline Consumer Healthcare (GSKCH)

相似试验